Patrizia Cavazzoni's FDA to Pfizer Move Epitomizes Regulatory Capture

confirmed Importance 9/10 ~1 min read 3 sources 7 actors

Media Capture & Control Regulatory Capture Financial Capture Federal Workforce Capture

Dr. Patrizia Cavazzoni, former head of the FDA’s Center for Drug Evaluation and Research (CDER), immediately transitioned to Pfizer as chief medical officer, reigniting intense debate about the pharmaceutical industry’s regulatory influence and the problematic ‘revolving door’ between government agencies and private corporations.

Sources & Citations

[1] Pfizer Hires FDA Drug Regulator Cavazzoni, Sparking Revolving Door Debate · Jan 15, 2025 Tier 2

[2] Top FDA Drug Regulator Returns to Pfizer: The Revolving Door Must End · Jan 15, 2025 Tier 2

[3] Patrizia Cavazzoni, Former Head of FDA's Drug Center, Joins Pfizer · Feb 24, 2025 Tier 1

Tiers Tier 1 court records & gov docs · Tier 2 established outlets · Tier 3 regional & specialty press · Tier 4 opinion or single-source. Methodology →

Cite this entry

The Cascade Ledger. “Patrizia Cavazzoni's FDA to Pfizer Move Epitomizes Regulatory Capture.” The Capture Cascade Timeline, January 15, 2025. https://capturecascade.org/event/2025-01-15--fda-cavazzoni-pfizer-revolving-door/